Search the Newsreel

Ovid Therapeutics (OVID) investor reports 9.6M-share beneficial stake

ADAR1 Capital Management, LLC and its manager Daniel Schneeberger have reported a beneficial ownership of 9,559,979 shares of Ovid Therapeutics (OVID) common stock, which represents 5.1% of the class. This includes shares held by various affiliated entities and warrants. The filing also notes an …

RA Capital reports 9.99% Ovid Therapeutics stake (OVID) via stock and warrants

RA Capital Management, L.P., along with Peter Kolchinsky and Rajeev Shah, has reported a beneficial ownership of 9.99% in Ovid Therapeutics (OVID) as of June 30, 2026. This stake, totaling 19,549,271 shares, includes direct common stock holdings and shares underlying pre-funded and Series B …

New Providence Acquisition III (NASDAQ: NPAC) details Abra merger plan and going-concern risks

New Providence Acquisition III (NPAC) has detailed its merger plan with Abra Financial Holdings and disclosed going-concern risks in its latest quarterly report. The SPAC reported a Q2 2026 net income of $2.24 million, primarily from trust investments, but faces substantial doubt about its …

New Providence Acquisition Corp. III Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Provident files Q3 2026 investor presentation highlighting $25.7B assets, $20.0B loans and strong capital

Provident Financial Services (PFS) has released its Q3 2026 investor presentation, showcasing its financial strength. Key highlights include $25.7 billion in total assets, $20.0 billion in total loans, and $19.5 billion in total deposits as of Q2 2026. The company also reported strong profitability …

Provident Financial Services (NYSE: PFS) showcases profitability, asset quality and liquidity

Provident Financial Services (NYSE: PFS) has released an investor presentation highlighting its strong financial performance, asset quality, and robust capital and liquidity position as of June 30, 2026. The bank boasts $25.7 billion in assets, significant profitability with a 1.26% annualized ROAA, solid asset …

Provident Financial Services, Inc Revenue Breakdown – NYSE:PFS

Provident Financial Services, Inc. (NYSE:PFS) generated $869.58 million in revenue last year. The Banking and Related Activities segment was the top performer, contributing $870.40 million. The United States accounted for the largest share of revenue, with $870.40 million.

Provident Financial (NASDAQ:PROV) Stock Passes Above 200 Day Moving Average - What's Next?

Form 8K Ovid Therapeutics Inc For: 13 August By Investing.com

This article announces that Ovid Therapeutics Inc. filed a Form 8K on August 13. The brief notice from Investing.com indicates that the filing is available for review, with the company's stock symbol OVID mentioned alongside a slight positive change.

Provident Financial (PROV) CEO uses 1,346 shares at $18.02 for tax withholding

Provident Financial Holdings Inc.'s President & CEO, Donavon P. Ternes, reported a Form 4 transaction where 1,346 shares were withheld by the issuer at $18.02 per share to cover tax obligations related to restricted stock vesting. This was not an open-market sale. Following this …

Provident Financial (PROV) SVP has shares withheld for taxes on vesting stock

Michael Scott Van Stockum, Senior Vice President of Provident Financial Holdings Inc. (PROV), reported a disposition of 272 shares of common stock. These shares were withheld by the company to cover tax obligations on vesting restricted stock. After this transaction, Van Stockum directly holds …

Provident Financial (PROV) SVP has 601 shares withheld to cover tax obligations

Provident Financial Holdings Inc. Senior Vice President Gwendolyn Wertz had 601 shares of common stock withheld by the issuer to cover tax obligations related to vesting restricted stock. The transaction occurred on August 12, 2026, at a price of $18.02 per share. Following this, …

Affinity Asset Advisors (OVID) discloses 15.1M-share Ovid stake with warrant cap

Affinity Asset Advisors, through its Affinity Healthcare Fund, LP, and Michael Cho, have disclosed a beneficial ownership of 15,143,728 shares of Ovid Therapeutics Inc. common stock, representing 7.9% of the outstanding shares as of June 30, 2026. This stake includes nearly 5 million shares …

Why Prairie Provident Resources Inc stock is plummeting today

Ovid Therapeutics (NASDAQ:OVID) Announces Earnings Results, Beats Estimates By $0.02 EPS

Ovid Therapeutics (NASDAQ:OVID) announced its quarterly earnings, reporting a loss of $0.08 per share, which beat analysts' estimates by $0.02. The company also surpassed revenue expectations, bringing in $0.73 million against a consensus of $0.02 million. Following the positive results, shares of OVID increased …

Ovid Therapeutics (NASDAQ:OVID) Stock Price Up 9% Following Better-Than-Expected Earnings

Ovid Therapeutics earnings beat by $0.04, revenue topped estimates

Ovid Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Ovid Therapeutics (OVID) Reports Q2 Loss, Beats Revenue Estimates

Ovid Therapeutics (OVID) reported a Q2 loss of $0.08 per share, exceeding the Zacks Consensus Estimate of a $0.1 loss, and revenues of $0.73 million, surpassing estimates by 388.67%. The company's stock has seen a significant gain of 60.7% year-to-date, outperforming the S&P 500, …

OVID Looks 59.6% Undervalued on GF Value™ Despite Challenging Fu

Ovid Therapeutics Inc (NASDAQ: OVID) reported strong Q2 2026 results with significant revenue growth, beating EPS expectations, but remains unprofitable and cash-flow-negative. While its Price-to-Sales ratio is lower than its historical median, suggesting potential undervaluation, its GF Score of 48/100 indicates mixed financial health …

Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results

Ovid Therapeutics (Nasdaq: OVID) has reported its business updates and second quarter 2026 financial results, highlighting advancements in its clinical pipeline with OV4071 and OV329. The company also detailed the monetization of soticlestat rights to a new company formed with Perceptive Advisors, which could …

Ovid’s OV329 enters Phase 2 study for treatment-resistant focal seizures

Ovid Therapeutics announced its Q2 2026 financial results, including a net loss of $15.0 million, but highlighted a strong cash position of $169.8 million, expected to fund operations until 2029. The company is advancing its pipeline with OV4071 in Phase 1 for schizophrenia and …

Ovid Therapeutics Inc. Q2 2026: Revenue $0.7M, EPS $(0.08) — 10-Q Summary

Ovid Therapeutics Inc. reported a significant decline in revenue and a wider net loss in Q2 2026 compared to the prior year, with revenue falling to $0.7M from $6.3M. The company's diluted EPS worsened to $(0.08) from $(0.06). This was primarily due to reduced …

Earnings Flash (PPR.TO) Prairie Provident Resources Inc. Reports Q2 Revenue C$11.5M

Earnings Flash (PPR.TO) Prairie Provident Resources Inc. Posts Q2 Net Loss C$0.14 per Share

Prairie Provident Resources Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Provident Financial (PROV) SVP has 27,482 direct shares after tax-withholding event

Robert Scott Ritter, Senior Vice President of Provident Financial Holdings Inc. (PROV), reported a tax-withholding event where 601 shares were withheld by the issuer to cover tax obligations related to vested restricted stock. Following this transaction, Ritter directly holds 27,482 shares, including 4,500 restricted …

Provident Financial Services (PFS) Could Be 9% Undervalued On Strong Q2 Earnings

Movida (MOVI3): o lucro dobrou no 2T26 e a ação caiu 28% no ano

Form 8K Provident Financial Services Inc For: 11 August By Investing.com

This article reports that Provident Financial Services Inc. has filed a Form 8K on August 11. The filing is brief and includes no further details within the main body of the content provided. The article mentions the stock symbol PFS and its current performance.

Movida (MOVI3) dobra lucro líquido, que fica em R$ 136 milhões no 2º tri

3 Savings & Loan Stocks Worth Picking on Improving Industry Prospects

The savings and loan industry is poised for growth due to higher interest rates, easing lending standards, and increasing loan demand, despite potential credit quality pressures from inflation. Digital transformation efforts are also contributing to improved profitability. The article highlights three specific stocks—WSFS Financial …

Oliver Luxxe Assets LLC Sells 42,681 Shares of Provident Financial Services, Inc $PFS

Oliver Luxxe Assets LLC significantly reduced its stake in Provident Financial Services by selling 42,681 shares, though institutional investors still hold a large portion of the company. Provident Financial Services reported strong Q2 earnings and revenue, exceeding analyst expectations, and declared a quarterly dividend …